Panacea Biotec bags LoA worth Rs 20.79 crore from CMSS
The company will supply Diphtheria and Tetanus Vaccine for Adults and Adolescents IP in several tranches to CMSS
Panacea Biotec has received a Letter of Award (LoA) worth Rs 20.79 crore from Central Medical Services Society, Ministry of Health and Family Welfare, Government of India (CMSS). The company will supply Diphtheria and Tetanus Vaccine (Absorbed) for Adults and Adolescents IP (Td Vaccine) in several tranches to CMSS starting from September / October 2026 till November / December 2028.
Panacea Biotec is a leading research-based Biotechnology Company with established research, manufacturing and marketing capabilities.
